NIA
PFE icon

NIA Impact Advisors’s Pfizer PFE Stock Holding History

NIA Impact Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
15,005
+1,526
+11% +$39.9K 0.15% 56
2026
Q1 		$378K Sell
13,479
-2,955
-18% -$78.7K 0.17% 76
2025
Q4 		$409K Buy
16,434
+2,461
+18% +$62.1K 0.14% 82
2025
Q3 		$356K Buy
13,973
+3,726
+36% +$92K 0.12% 84
2025
Q2 		$248K Buy
10,247
+1,027
+11% +$24K 0.09% 89
2025
Q1 		$234K Buy
9,220
+109
+1% +$2.85K 0.09% 92
2024
Q4 		$242K Buy
9,111
+642
+8% +$17.4K 0.08% 106
2024
Q3 		$245K Buy
8,469
+324
+4% +$9.45K 0.08% 97
2024
Q2 		$228K Buy
8,145
+563
+7% +$15.5K 0.08% 96
2024
Q1 		$210K Buy
+7,582
New +$210K 0.08% 88

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

NIA Impact Advisors's PFE Position: Q2 2026 in Review

NIA Impact Advisors increased its Pfizer (PFE) stake by 11% in Q2 2026, buying an estimated $39.9K and bringing the position to 15,005 shares worth $361K. The position accounts for 0.15% of the portfolio, ranked #56.

NIA Impact Advisors first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $409K in Q4 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NIA Impact Advisors held 15,005 shares of Pfizer worth $361K as of Q2 2026.
  • NIA Impact Advisors bought 1,526 Pfizer shares in Q2 2026, an estimated $39.9K.
  • Pfizer made up 0.15% of NIA Impact Advisors's portfolio in Q2 2026, its #56 holding.
  • NIA Impact Advisors first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • NIA Impact Advisors's Pfizer position peaked at $409K in Q4 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NIA Impact Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.